Diagenic, Opaldia unite for UK blood test deal
This article was originally published in Clinica
Executive Summary
Norwegian lifesciences specialist DiaGenic has teamed up with healthcare provider Opaldia to make its gene expression tests available in the UK. The two companies will make the technology, which consists of tests for Alzheimer's disease and breast cancer, available to private patients in the UK.